First Long Island Investors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.6M Sell
69,987
-650
-0.9% -$232K 2% 20
2025
Q4
$23.1M Buy
70,637
+86
+0.1% +$27.3K 1.7% 23
2025
Q3
$19.9M Sell
70,551
-404
-0.6% -$117K 1.48% 29
2025
Q2
$19.8M Sell
70,955
-896
-1% -$254K 1.56% 26
2025
Q1
$22.4M Sell
71,851
-10,950
-13% -$3.23M 1.84% 21
2024
Q4
$21.6M Buy
82,801
+60
+0.1% +$17.8K 1.72% 22
2024
Q3
$26.7M Sell
82,741
-400
-0.5% -$131K 2.1% 17
2024
Q2
$26M Sell
83,141
-1,746
-2% -$513K 2.2% 14
2024
Q1
$24.1M Sell
84,887
-1,790
-2% -$524K 2.01% 19
2023
Q4
$25M Sell
86,677
-1,796
-2% -$489K 2.22% 17
2023
Q3
$23.8M Buy
88,473
+293
+0.3% +$73.1K 2.3% 15
2023
Q2
$19.6M Buy
88,180
+659
+0.8% +$153K 1.88% 23
2023
Q1
$21.2M Sell
87,521
-6,540
-7% -$1.61M 2.15% 18
2022
Q4
$24.7M Sell
94,061
-643
-0.7% -$172K 2.59% 14
2022
Q3
$21.3M Sell
94,704
-791
-0.8% -$192K 2.37% 16
2022
Q2
$23.2M Sell
95,495
-4,057
-4% -$994K 2.42% 16
2022
Q1
$24.1M Buy
99,552
+20,009
+25% +$4.6M 2.05% 19
2021
Q4
$17.9M Sell
79,543
-39,250
-33% -$8.28M 1.41% 34
2021
Q3
$25.3M Buy
118,793
+3,524
+3% +$811K 2.16% 17
2021
Q2
$28.1M Sell
115,269
-18,099
-14% -$4.45M 2.41% 15
2021
Q1
$33.2M Sell
133,368
-647
-0.5% -$154K 2.95% 13
2020
Q4
$30.8M Buy
134,015
+23,037
+21% +$5.31M 2.88% 14
2020
Q3
$28.2M Buy
110,978
+364
+0.3% +$90.2K 2.91% 13
2020
Q2
$26.1M Buy
110,614
+1,496
+1% +$341K 2.96% 10
2020
Q1
$22.1M Buy
109,118
+3,187
+3% +$696K 3.01% 8
2019
Q4
$25.5M Sell
105,931
-575
-0.5% -$127K 2.86% 9
2019
Q3
$20.6M Sell
106,506
-712
-0.7% -$137K 2.53% 11
2019
Q2
$19.8M Sell
107,218
-10,219
-9% -$1.83M 2.45% 12
2019
Q1
$22.3M Buy
117,437
+3,844
+3% +$734K 2.88% 9
2018
Q4
$22.1M Sell
113,593
-9,928
-8% -$1.94M 3.28% 5
2018
Q3
$25.6M Buy
123,521
+2,909
+2% +$573K 3.32% 4
2018
Q2
$22.3M Sell
120,612
-11,063
-8% -$1.96M 3.18% 6
2018
Q1
$22.4M Buy
131,675
+1,206
+0.9% +$221K 3.1% 5
2017
Q4
$22.7M Buy
130,469
+1,960
+2% +$347K 3.08% 5
2017
Q3
$24M Buy
128,509
+11,089
+9% +$1.96M 3.47% 2
2017
Q2
$20.2M Buy
117,420
+24,426
+26% +$3.97M 3.14% 3
2017
Q1
$15.3M Buy
92,994
+1,819
+2% +$302K 2.53% 10
2016
Q4
$13.3M Buy
91,175
+1,546
+2% +$233K 2.32% 11
2016
Q3
$15M Sell
89,629
-797
-0.9% -$135K 2.71% 7
2016
Q2
$13.8M Buy
90,426
+2,582
+3% +$401K 2.55% 9
2016
Q1
$13.2M Buy
+87,844
New +$13.1M 2.51% 10

Other funds holding AMGN

First Long Island Investors's AMGN Position: Q1 2026 in Review

First Long Island Investors reduced its Amgen (AMGN) stake by 0.92% in Q1 2026, selling an estimated $232K and leaving 69,987 shares worth $24.6M. The position accounts for 2% of the portfolio, ranked #20.

First Long Island Investors first reported a position in AMGN in Q1 2016 and has held it in 41 quarters since. The position peaked at $33.2M in Q1 2021. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • First Long Island Investors held 69,987 shares of Amgen worth $24.6M as of Q1 2026.
  • First Long Island Investors sold 650 Amgen shares in Q1 2026, an estimated $232K.
  • Amgen made up 2% of First Long Island Investors's portfolio in Q1 2026, its #20 holding.
  • First Long Island Investors first reported a position in Amgen in Q1 2016 and has held it in 41 quarters since.
  • First Long Island Investors's Amgen position peaked at $33.2M in Q1 2021.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on First Long Island Investors's 13F filing for Q1 2026, filed 15 May 2026.